A consultation will determine if Klow alone or in combination with other treatments is right for you
My key takeaways: People who take the pill can maintain their weight loss for up to a year after treatment with injectable GLP-1 medicines The trial also found promise for people who had previously used GLP-1 injections and reached a weight-loss plateau, helping to prevent weight regain A significantly reduced appetite, caused by this medication, increases the risk of malnutrition if nutrition isnt carefully managed Gastrointestinal side effects may be improved through dietary support, including fibre, hydration and regular meal timing Less than 5% of people accessing these drugs are doing so through their doctor or the NHS, meaning the risks are higher, particularly if you dont have weight to lose Limitations: 1 year duration not for life as some headlines suggest, no comparator arm using the injectables so not directly compared to continuing the existing drug and funded by Eli Lily who make the drug This is an exciting advance in medical science but it requires careful consideration and nuance
Combining with Other Therapies Micro-dosing BPC-157 often works best as part of a comprehensive approach to chronic condition management
This can be dangerous in certain situations
In a separate study in adult patients, FARXIGA provided additional benefit of SBP reduction as an add-on to metformin at 1 year (exploratory endpoint) 1,4 Primary Endpoint: 0.5% mean reduction in A1C from BL (n=400
